Europe Immunohistochemistry Market Key Players and Opportunities by 2028

The Europe immunohistochemistry market is expected to grow from US$ 631.33 million in 2021 to US$ 1,022.27 million by 2028; it is estimated to grow at a CAGR of 7.1% from 2021 to 2028.

The UK, Germany, France, Italy, and Spain are major economies in Europe. Growing R&D investments by biotechnology & biopharmaceutical companies is expected to fuel the market growth. In recent years, the biotechnology industry is developing at an extraordinarily rapid speed. Manufacturers are confronting to the various healthcare difficulties through the latest medicines, progressing digitalization, therapy forms, and continuously changing the management. As per the statistics from the World Health Organization (WHO), the population is rising by 1.2% per annum, leading to growth in population in the elderly class. The WHO also reveals that the balance of people aged 65 to 80 will increase to 28% in 2030, as compared to 22% in 2000. Additionally, rising urbanization and a growing number of middle-income people results in drug makers manufacturing reasonable medicines is responsible to drive the growth of the market. These formulations are produced in the market after passing through strict regulatory guidelines for patient safety. Research & development expenses compared to the methods of exploring, examining, and producing innovative products, upfront payments, and milestones, enhancing products, and exhibiting product efficiency and regulatory compliance before launch. Thus, the high research investment by investors, biopharmaceutical, and biotechnology industries are expected to propel the growth of the immunohistochemistry market over the forecast years. The increasing investments in R&D activities have paved the way for the growth of the industry in the future years. Many scientists, in partnership with other scientists, offer various products for bioreactors. These factors are expected to increase biotechnology and biopharmaceutical industries to achieve efficient tests which are predicted to drive the growth of the Europe market.

Countries in Europe, especially France, are highly affected due to the COVID-19 outbreak. Coronavirus immunohistochemistry antibodies are immunological methods that can be used to identify members of the Coronaviridae family of RNA viruses that infect birds and mammals. Antibodies against antigens expressed by several coronavirus strains, such as SARS-CoV-2, SARS-CoV, MERS, and other non-human pathogens like feline coronavirus, are listed below. Common coronavirus antibody targets include nucleocapsid (N) and spike glycoprotein (S). These antibodies are intended for immunohistochemical applications. Immunohistochemistry analysis shows the detection of differential expression levels of SARS-CoV-2 Coronavirus Nucleocapsid and demonstrates antibody specificity. Immunohistochemical analysis of SARS-CoV-2 Coronavirus NP using SARS/SARS-CoV-2 Coronavirus NP Monoclonal Antibody (B46F) (Cat. No. MA1-7404) shows significant staining in human lung and placenta tissues infected with SARS-CoV-2 when compared to the control tissues without SARS-CoV-2. Researchers from the UK and Sweden recently used extremely sensitive multiplexed immunohistochemistry to examine ACE2 expression in brain pericytes of patients with neurological symptoms in COVID-19 patients and controls. They also used spatial immunophenotyping to evaluate inflammation in COVID-19 patients' brain tissue. 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe immunohistochemistry market. The Europe immunohistochemistry market is expected to grow at a good CAGR during the forecast period. 

Europe Immunohistochemistry Market Segmentation    

Europe Immunohistochemistry Market – By Product

• Equipment
  • Slide Staining Systems
  • Tissue Microarray Systems
  • Tissue Processing Systems
  • Slide Scanners
  • Other Equipment
• Antibodies
  • Primary Antibodies
  • Secondary Antibodies
• Reagents
  • Histological Stains
  • Blocking and Fixation Reagents
  • Chromogenic Substrates
  • Fixation Reagents
  • Stabilizers
  • Organic Solvents
  • Proteolytic Enzymes
  • Diluents
• Kits

Europe Immunohistochemistry Market – By Application

• Diagnostics
  • Cancer
  • Infectious Diseases
  • Autoimmune Diseases
  • Diabetes Mellitus
  • Nephrological Diseases
  • Others
• Drug Testing

Europe Immunohistochemistry Market – By End User

• Hospitals and Diagnostic Laboratories
• Research Institutes
• Others

Europe Immunohistochemistry Market, by Country

• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe

Europe Immunohistochemistry Market - Companies Mentioned

• Abcam plc
• Agilent Technologies, Inc.
• Bio SB
• BIO-RAD LABORATORIES INC.
• Cell Signaling Technology, Inc.  
• Danaher
• F. HOFFMANN-LA ROCHE LTD.
• MERCK KGaA
• PerkinElmer Inc.
• THERMO FISHER SCIENTIFIC INC.

Europe Immunohistochemistry Report Scope